0 XP   0   0   0

Mdxhealth
Buy, Hold or Sell?

Should you buy, hold or sell Mdxhealth?

I guess you are interested in Mdxhealth. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Mdxhealth

Let's start. I'm going to help you getting a better view of Mdxhealth. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Mdxhealth even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Mdxhealth is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Mdxhealth. The closing price on 2023-01-26 was €0.634 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Mdxhealth Daily Candlestick Chart
Mdxhealth Daily Candlestick Chart
Summary









1. Valuation of Mdxhealth




Current price per share

€0.63

2. Growth of Mdxhealth




Is Mdxhealth growing?

Current yearPrevious yearGrowGrow %
How rich?$46.8m$5.8m$41m87.5%

How much money is Mdxhealth making?

Current yearPrevious yearGrowGrow %
Making money-$28.9m-$28.6m-$339.9k-1.2%
Net Profit Margin-130.4%-156.0%--

How much money comes from the company's main activities?

3. Financial Health of Mdxhealth




Comparing to competitors in the Diagnostics & Research industry




  Industry Rankings (Diagnostics & Research)  


Richest
#108 / 171

Most Revenue
#107 / 171

Most Profit
#145 / 171

Most Efficient
#128 / 171


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Mdxhealth.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mdxhealth earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -130.4% means that €-1.30 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mdxhealth:

  • The MRQ is -130.4%. The company is making a huge loss. -2
  • The TTM is -130.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-130.4%TTM-130.4%0.0%
TTM-130.4%YOY-156.0%+25.6%
TTM-130.4%5Y-159.3%+28.9%
5Y-159.3%10Y-146.3%-13.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-130.4%-7.3%-123.1%
TTM-130.4%-4.9%-125.5%
YOY-156.0%0.5%-156.5%
5Y-159.3%-5.8%-153.5%
10Y-146.3%-3.4%-142.9%
1.1.2. Return on Assets

Shows how efficient Mdxhealth is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • -38.6% Return on Assets means that Mdxhealth generated €-0.39 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mdxhealth:

  • The MRQ is -38.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -38.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.6%TTM-38.6%0.0%
TTM-38.6%YOY-90.0%+51.3%
TTM-38.6%5Y-61.0%+22.4%
5Y-61.0%10Y-51.3%-9.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.6%-0.5%-38.1%
TTM-38.6%-0.4%-38.2%
YOY-90.0%0.2%-90.2%
5Y-61.0%-0.8%-60.2%
10Y-51.3%-0.8%-50.5%
1.1.3. Return on Equity

Shows how efficient Mdxhealth is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • -61.8% Return on Equity means Mdxhealth generated €-0.62 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mdxhealth:

  • The MRQ is -61.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -61.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-61.8%TTM-61.8%0.0%
TTM-61.8%YOY-490.0%+428.2%
TTM-61.8%5Y-172.2%+110.3%
5Y-172.2%10Y-112.3%-59.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.8%0.7%-62.5%
TTM-61.8%0.3%-62.1%
YOY-490.0%0.6%-490.6%
5Y-172.2%-1.3%-170.9%
10Y-112.3%-1.8%-110.5%

1.2. Operating Efficiency of Mdxhealth.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mdxhealth is operating .

  • Measures how much profit Mdxhealth makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • An Operating Margin of -122.0% means the company generated €-1.22  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mdxhealth:

  • The MRQ is -122.0%. The company is operating very inefficient. -2
  • The TTM is -122.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-122.0%TTM-122.0%0.0%
TTM-122.0%YOY-148.7%+26.7%
TTM-122.0%5Y-156.7%+34.7%
5Y-156.7%10Y-144.4%-12.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-122.0%0.3%-122.3%
TTM-122.0%-1.8%-120.2%
YOY-148.7%1.1%-149.8%
5Y-156.7%-2.5%-154.2%
10Y-144.4%-1.6%-142.8%
1.2.2. Operating Ratio

Measures how efficient Mdxhealth is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.21 means that the operating costs are €2.21 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Mdxhealth:

  • The MRQ is 2.207. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.207. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.207TTM2.2070.000
TTM2.207YOY2.476-0.269
TTM2.2075Y2.556-0.349
5Y2.55610Y2.440+0.116
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2071.329+0.878
TTM2.2071.234+0.973
YOY2.4761.234+1.242
5Y2.5561.103+1.453
10Y2.4401.031+1.409

1.3. Liquidity of Mdxhealth.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mdxhealth is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.05 means the company has €4.05 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Mdxhealth:

  • The MRQ is 4.053. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.053. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.053TTM4.0530.000
TTM4.053YOY1.773+2.280
TTM4.0535Y3.192+0.862
5Y3.19210Y3.862-0.670
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0532.412+1.641
TTM4.0532.617+1.436
YOY1.7732.767-0.994
5Y3.1922.626+0.566
10Y3.8622.837+1.025
1.3.2. Quick Ratio

Measures if Mdxhealth is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.84 means the company can pay off €3.84 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mdxhealth:

  • The MRQ is 3.839. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.839. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.839TTM3.8390.000
TTM3.839YOY1.524+2.315
TTM3.8395Y2.976+0.863
5Y2.97610Y3.647-0.671
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8391.321+2.518
TTM3.8391.454+2.385
YOY1.5241.515+0.009
5Y2.9761.553+1.423
10Y3.6471.530+2.117

1.4. Solvency of Mdxhealth.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mdxhealth assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mdxhealth to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.38 means that Mdxhealth assets are financed with 37.5% credit (debt) and the remaining percentage (100% - 37.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mdxhealth:

  • The MRQ is 0.375. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.375. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.375TTM0.3750.000
TTM0.375YOY0.816-0.441
TTM0.3755Y0.433-0.058
5Y0.43310Y0.322+0.112
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3750.404-0.029
TTM0.3750.404-0.029
YOY0.8160.433+0.383
5Y0.4330.453-0.020
10Y0.3220.442-0.120
1.4.2. Debt to Equity Ratio

Measures if Mdxhealth is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 60.1% means that company has €0.60 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mdxhealth:

  • The MRQ is 0.601. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.601. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.6010.000
TTM0.601YOY4.446-3.846
TTM0.6015Y1.341-0.741
5Y1.34110Y0.804+0.537
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6010.598+0.003
TTM0.6010.620-0.019
YOY4.4460.672+3.774
5Y1.3410.753+0.588
10Y0.8040.741+0.063

2. Market Valuation of Mdxhealth

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Mdxhealth generates.

  • Above 15 is considered overpriced but always compare Mdxhealth to the Diagnostics & Research industry mean.
  • A PE ratio of -5.40 means the investor is paying €-5.40 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mdxhealth:

  • The EOD is -3.879. Company is losing money. -2
  • The MRQ is -5.396. Company is losing money. -2
  • The TTM is -5.396. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.879MRQ-5.396+1.517
MRQ-5.396TTM-5.3960.000
TTM-5.396YOY-5.509+0.114
TTM-5.3965Y-14.330+8.935
5Y-14.33010Y-30.063+15.732
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-3.879-1.994-1.885
MRQ-5.396-2.312-3.084
TTM-5.396-4.930-0.466
YOY-5.509-0.548-4.961
5Y-14.330-1.611-12.719
10Y-30.063-1.973-28.090
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Mdxhealth.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Mdxhealth:

  • The MRQ is -5.461. Very Bad. -2
  • The TTM is -5.461. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-5.461TTM-5.4610.000
TTM-5.461YOY-4.127-1.334
TTM-5.4615Y-8.721+3.260
5Y-8.72110Y-29.406+20.685
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.461-0.052-5.409
TTM-5.4610.036-5.497
YOY-4.1270.113-4.240
5Y-8.7210.023-8.744
10Y-29.4060.023-29.429

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mdxhealth is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.34 means the investor is paying €3.34 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Mdxhealth:

  • The EOD is 2.399. Good. +1
  • The MRQ is 3.337. Neutral. Compare to industry.
  • The TTM is 3.337. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.399MRQ3.337-0.938
MRQ3.337TTM3.3370.000
TTM3.337YOY26.998-23.661
TTM3.3375Y11.814-8.477
5Y11.81410Y16.805-4.992
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.3992.021+0.378
MRQ3.3372.205+1.132
TTM3.3373.188+0.149
YOY26.9984.346+22.652
5Y11.8143.414+8.400
10Y16.8053.056+13.749
2. Total Gains per Share

2.4. Latest News of Mdxhealth

Does Mdxhealth still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Mdxhealth to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-20
07:00
MDxHealth Provides Updated and Supplemental Financial Information Related to Acquisition of GPS TestRead
2023-01-09
22:00
MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue GuidanceRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Mdxhealth compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2310.2310%-0.078+134%-0.007+103%0.018+1174%
Book Value Growth--8.0188.0180%0.297+2604%2.143+274%1.736+362%
Book Value Per Share--0.2640.2640%0.033+702%0.190+39%0.186+42%
Book Value Per Share Growth--8.0188.0180%0.297+2604%2.143+274%1.736+362%
Current Ratio--4.0534.0530%1.773+129%3.192+27%3.862+5%
Debt To Asset Ratio--0.3750.3750%0.816-54%0.433-13%0.322+17%
Debt To Equity Ratio--0.6010.6010%4.446-86%1.341-55%0.804-25%
Dividend Per Share----0%-0%-0%-0%
Eps---0.163-0.1630%-0.162-1%-0.164+0%-0.122-25%
Eps Growth--0.9880.9880%1.335-26%0.684+44%0.794+24%
Free Cash Flow Per Share---0.132-0.1320%-0.117-11%-0.126-5%-0.111-16%
Free Cash Flow Per Share Growth--0.8720.8720%1.071-19%0.906-4%0.849+3%
Free Cash Flow To Equity Per Share--0.2430.2430%-0.037+115%0.033+638%0.029+728%
Free Cash Flow To Equity Per Share Growth--8.6338.6330%0.524+1548%-5.164+160%-0.875+110%
Gross Profit Margin--1.0891.0890%1.081+1%1.243-12%1.293-16%
Intrinsic Value_10Y_max---0.470--------
Intrinsic Value_10Y_min---0.868--------
Intrinsic Value_1Y_max---0.109--------
Intrinsic Value_1Y_min---0.122--------
Intrinsic Value_3Y_max---0.279--------
Intrinsic Value_3Y_min---0.338--------
Intrinsic Value_5Y_max---0.393--------
Intrinsic Value_5Y_min---0.522--------
Net Profit Margin---1.304-1.3040%-1.560+20%-1.593+22%-1.463+12%
Operating Margin---1.220-1.2200%-1.487+22%-1.567+28%-1.444+18%
Operating Ratio--2.2072.2070%2.476-11%2.556-14%2.440-10%
Pb Ratio2.399-39%3.3373.3370%26.998-88%11.814-72%16.805-80%
Pe Ratio-3.879+28%-5.396-5.3960%-5.509+2%-14.330+166%-30.063+457%
Peg Ratio---5.461-5.4610%-4.127-24%-8.721+60%-29.406+438%
Price Per Share0.634-39%0.8820.8820%0.890-1%1.574-44%2.617-66%
Price To Total Gains Ratio2.740-39%3.8123.8120%-11.381+399%-7.382+294%-60.657+1691%
Profit Growth--0.9880.9880%1.335-26%0.684+44%0.794+24%
Quick Ratio--3.8393.8390%1.524+152%2.976+29%3.647+5%
Return On Assets---0.386-0.3860%-0.900+133%-0.610+58%-0.513+33%
Return On Equity---0.618-0.6180%-4.900+692%-1.722+178%-1.123+82%
Revenue Growth--1.2101.2100%1.559-22%1.047+16%1.298-7%
Total Gains Per Share--0.2310.2310%-0.078+134%-0.007+103%0.018+1174%
Total Gains Per Share Growth--4.9594.9590%1.572+215%0.920+439%4.343+14%
Usd Book Value--46889329.42646889329.4260%5847793.936+702%33620066.113+39%32940787.231+42%
Usd Book Value Change Per Share--0.2520.2520%-0.085+134%-0.007+103%0.020+1174%
Usd Book Value Per Share--0.2880.2880%0.036+702%0.206+39%0.202+42%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.178-0.1780%-0.176-1%-0.179+0%-0.133-25%
Usd Free Cash Flow---23439165.847-23439165.8470%-20776714.958-11%-22360188.378-5%-19681738.557-16%
Usd Free Cash Flow Per Share---0.144-0.1440%-0.128-11%-0.137-5%-0.121-16%
Usd Free Cash Flow To Equity Per Share--0.2640.2640%-0.040+115%0.036+638%0.032+728%
Usd Price Per Share0.690-39%0.9610.9610%0.969-1%1.715-44%2.850-66%
Usd Profit---28996019.788-28996019.7880%-28656089.896-1%-29094399.498+0%-21640618.541-25%
Usd Revenue--22234414.31822234414.3180%18368211.694+21%24255197.547-8%19418212.591+15%
Usd Total Gains Per Share--0.2520.2520%-0.085+134%-0.007+103%0.020+1174%
 EOD+2 -3MRQTTM+0 -0YOY+28 -125Y+31 -910Y+28 -12

3.2. Fundamental Score

Let's check the fundamental score of Mdxhealth based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.879
Price to Book Ratio (EOD)Between0-12.399
Net Profit Margin (MRQ)Greater than0-1.304
Operating Margin (MRQ)Greater than0-1.220
Quick Ratio (MRQ)Greater than13.839
Current Ratio (MRQ)Greater than14.053
Debt to Asset Ratio (MRQ)Less than10.375
Debt to Equity Ratio (MRQ)Less than10.601
Return on Equity (MRQ)Greater than0.15-0.618
Return on Assets (MRQ)Greater than0.05-0.386
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Mdxhealth based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.902
Ma 20Greater thanMa 500.642
Ma 50Greater thanMa 1000.657
Ma 100Greater thanMa 2000.681
OpenGreater thanClose0.630
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets75,072
Total Liabilities28,173
Total Stockholder Equity46,899
 As reported
Total Liabilities 28,173
Total Stockholder Equity+ 46,899
Total Assets = 75,072

Assets

Total Assets75,072
Total Current Assets66,606
Long-term Assets66,606
Total Current Assets
Cash And Cash Equivalents 58,498
Net Receivables 4,582
Inventory 1,911
Total Current Assets  (as reported)66,606
Total Current Assets  (calculated)64,991
+/- 1,615
Long-term Assets
Property Plant Equipment 5,018
Intangible Assets 3,448
Long-term Assets  (as reported)8,466
Long-term Assets  (calculated)8,466
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,432
Long-term Liabilities11,741
Total Stockholder Equity46,899
Total Current Liabilities
Short-term Debt 5,281
Short Long Term Debt 4,441
Accounts payable 7,455
Other Current Liabilities 3,696
Total Current Liabilities  (as reported)16,432
Total Current Liabilities  (calculated)20,873
+/- 4,441
Long-term Liabilities
Long term Debt 7,651
Capital Lease Obligations 3,464
Other Liabilities 1,466
Long-term Liabilities  (as reported)11,741
Long-term Liabilities  (calculated)12,581
+/- 840
Total Stockholder Equity
Common Stock128,454
Retained Earnings -244,302
Other Stockholders Equity 162,747
Total Stockholder Equity (as reported)46,899
Total Stockholder Equity (calculated)46,899
+/-0
Other
Capital Stock128,454
Cash and Short Term Investments 58,498
Common Stock Shares Outstanding 120,842
Liabilities and Stockholders Equity 75,072
Net Debt -42,942
Net Invested Capital 58,991
Net Tangible Assets 43,451
Net Working Capital 50,174
Short Long Term Debt Total 15,556



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
5,869
8,764
16,809
48,537
58,180
54,364
35,463
19,177
19,042
20,002
29,384
30,953
57,742
67,721
58,521
65,476
40,628
31,856
75,072
75,07231,85640,62865,47658,52167,72157,74230,95329,38420,00219,04219,17735,46354,36458,18048,53716,8098,7645,869
   > Total Current Assets 
0
7,483
14,426
45,763
53,184
47,877
32,632
17,702
18,043
18,907
27,622
28,113
44,646
51,488
39,316
47,863
30,907
23,091
66,606
66,60623,09130,90747,86339,31651,48844,64628,11327,62218,90718,04317,70232,63247,87753,18445,76314,4267,4830
       Cash And Cash Equivalents 
887
310
11,158
43,301
48,264
42,600
25,835
14,088
14,416
15,492
24,683
18,897
30,520
30,506
16,827
26,203
22,050
15,953
58,498
58,49815,95322,05026,20316,82730,50630,52018,89724,68315,49214,41614,08825,83542,60048,26443,30111,158310887
       Short-term Investments 
3,837
4,408
8
5
21
27
19
27
20
13
44
43
79
45
20
54
0
0
0
000542045794344132027192721584,4083,837
       Net Receivables 
107
651
2,551
1,525
2,854
3,361
4,189
2,310
2,554
2,201
2,234
7,993
11,206
18,498
19,931
19,132
6,695
3,894
4,582
4,5823,8946,69519,13219,93118,49811,2067,9932,2342,2012,5542,3104,1893,3612,8541,5252,551651107
       Inventory 
0
0
0
17
58
99
82
108
63
123
171
860
1,427
1,479
1,919
1,807
1,192
2,324
1,911
1,9112,3241,1921,8071,9191,4791,4278601711236310882995817000
   > Long-term Assets 
0
1,281
2,383
2,774
4,997
6,487
2,831
1,475
999
1,095
1,762
2,840
13,096
16,233
19,205
17,613
9,721
8,765
8,466
8,4668,7659,72117,61319,20516,23313,0962,8401,7621,0959991,4752,8316,4874,9972,7742,3831,2810
       Property Plant Equipment 
333
691
628
1,982
2,549
1,989
1,464
770
942
1,058
781
724
1,888
2,259
2,568
2,074
2,452
3,707
5,018
5,0183,7072,4522,0742,5682,2591,8887247811,0589427701,4641,9892,5491,982628691333
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
1,145
1,145
1,145
1,145
0
0
0
0001,1451,1451,1451,145000000000000
       Intangible Assets 
487
522
321
227
106
2,289
70
63
57
37
981
2,011
10,030
12,829
15,492
14,394
7,269
5,058
3,448
3,4485,0587,26914,39415,49212,82910,0302,011981375763702,289106227321522487
       Other Assets 
0
50
1,211
428
1,606
1,087
405
483
0
0
0
105
33
0
19,205
0
0
0
0
000019,2050331050004834051,0871,6064281,211500
> Total Liabilities 
384
1,720
4,860
6,330
8,430
8,922
8,528
4,916
4,370
3,977
4,847
7,177
13,480
14,980
14,975
13,359
20,904
26,007
28,173
28,17326,00720,90413,35914,97514,98013,4807,1774,8473,9774,3704,9168,5288,9228,4306,3304,8601,720384
   > Total Current Liabilities 
384
1,559
3,088
5,467
6,471
7,179
7,730
4,083
4,008
3,954
4,847
7,094
10,825
12,593
13,115
11,477
10,427
13,021
16,432
16,43213,02110,42711,47713,11512,59310,8257,0944,8473,9544,0084,0837,7307,1796,4715,4673,0881,559384
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
440
430
191
147
0
2,818
5,281
5,2812,8180147191430440000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
440
430
191
147
565
2,818
4,441
4,4412,818565147191430440000000000000
       Accounts payable 
128
439
498
1,286
1,249
6,232
3,841
2,069
2,623
1,661
3,271
5,264
6,610
7,546
8,055
6,453
4,958
5,320
7,455
7,4555,3204,9586,4538,0557,5466,6105,2643,2711,6612,6232,0693,8416,2321,2491,286498439128
       Other Current Liabilities 
256
1,559
3,088
5,467
6,471
947
3,888
2,014
1,384
3,954
1,576
1,830
4,215
5,047
5,060
5,024
5,469
4,883
3,696
3,6964,8835,4695,0245,0605,0474,2151,8301,5763,9541,3842,0143,8889476,4715,4673,0881,559256
   > Long-term Liabilities 
0
161
1,772
863
1,960
1,743
798
833
363
22
0
83
2,655
2,387
1,860
1,882
10,477
12,986
11,741
11,74112,98610,4771,8821,8602,3872,655830223638337981,7431,9608631,7721610
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
408
108
523
262
9,787
0
0
009,787262523108408000000000000
       Other Liabilities 
0
107
1,491
652
1,343
1,252
557
624
280
17
0
83
2,247
2,279
1,337
1,620
690
690
1,466
1,4666906901,6201,3372,2792,247830172806245571,2521,3436521,4911070
> Total Stockholder Equity
5,485
7,044
11,949
42,207
49,750
45,442
26,936
14,261
14,672
16,025
24,537
23,776
44,262
52,741
43,546
52,117
19,724
5,849
46,899
46,8995,84919,72452,11743,54652,74144,26223,77624,53716,02514,67214,26126,93645,44249,75042,20711,9497,0445,485
   Common Stock
9,535
19,252
27,480
53,620
66,311
70,982
73,198
13,989
18,156
25,330
35,483
37,825
42,791
45,853
45,946
53,877
62,841
76,716
128,454
128,45476,71662,84153,87745,94645,85342,79137,82535,48325,33018,15613,98973,19870,98266,31153,62027,48019,2529,535
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 0-7,983-6,600-5,333-4,627-4,096-3,365-2,789-2,510-3,210-3,010-2,825-3,251000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
83,118
101,105
101,239
135,731
136,349
0
0
00136,349135,731101,239101,10583,118000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
323
489
2,678
13,546
-11,351
21,667
20,154
25,152
31,924
47,385
59,893
90,462
109,784
113,315
147,111
150,121
152,416
162,747
162,747152,416150,121147,111113,315109,78490,46259,89347,38531,92425,15220,15421,667-11,35113,5462,6784893230



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.